Santhera's CSO Thomas Meier Receives BioValley Award for Scientific and Entrepreneurial Merits
At the award ceremony, Rolf Rolli, Vice President of BioValley Basel, praised Thomas Meier as an outstanding scientist and example for other ambitious researchers: "Thomas Meier was infected with the entrepreneurial virus during his postdoctoral research stay in the U. S. and has been addicted to this spirit ever since. Back in Switzerland, he founded MyoContract as the first life sciences spin-off from the Biozentrum of the University of Basel. In 2004, at the creation of Santhera, he fostered a greater vision as an entrepreneur in which he became Chief Scientific Officer of the new company to focus on his main strengths, which are the scientific work and the understanding of neuromuscular biological processes."
The BioValley Basel Association created the BioValley Basel Award in 2002 with the purpose of honoring outstanding contributions to the Life Sciences in the BioValley. With the "Goldig Läggerli" award, the jury, consisting of the Board of BioValley Basel, pays tribute to persons who have had a substantial and lasting impact on Life Sciences in science, medicine, business and public policy in the greater Basel area. Previous prizewinners include the founding team of Actelion, Prof Dr Hans-Joachim Güntherodt and Prof G Schatz (University of Basel), Dr Jürg Meier (Novartis Venture Fund) and Dr h .c. Georg H. Endress (Endress+Hauser).
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.